Measurement of low-density lipoprotein particle size by high-performance gel-filtration chromatography

Clinical Chemistry

Volumn 43, Issue 10, 1997, Pages 1904-1912

  Scheffer, Peter G ^a   Bakker, Stephan J L ^a   Heine, Robert J ^a   Teerlink, Tom ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; FEMALE; GEL ELECTROPHORESIS; GEL FILTRATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE;

EID: 0030767121     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.10.1904     Document Type: Article

References (44)

1. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992;12:1284-90.
2. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993;34:1687-97.
3. Lagrost L, Cambert P, Lallemant C. Combined effects of lipid transfers and lipolysis on gradient gel patterns of human plasma LDL. Arterioscler Thromb 1994;14:1327-36.
4. Austin MA, Mykkänen L, Kuusisto J, Edwards KL, Nelson C, Haffner SM, et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 1995;92:1770-8.
5. Austin MA, Krauss RM. Genetic control of low-density-lipoprotein subclasses. Lancet 1986;ii:592-5.
6. Campos H, Genest JJ Jr, Blijlevens E, McNamara JR, Jennner JL, Ordovas JM, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992;12: 187-95.
7. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988:260:1917-21.
8. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-81.
9. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882-8.
10. Lamarche B, Tchernof A., Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997;95:69-75.
11. Jaakkola O, Solakivi T, Ylä-Herttuala S, Nikkari T. Receptor-mediated binding and degradation of subfractions of human plasma low-density lipoprotein by cultured fibroblasts. Biochim Biophys Acta 1989;1005:118-22.
12. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Ngu'yen TD, et al. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem 1994;269: 511-9.
13. Campos H, Arnold KS, Balestra ME, Innerarity TL, Krauss RM. Differences in receptor binding of LDL subfractions. Arterioscler Thromb Vasc Biol 1996;16:794-801.
14. Parthasarathy S, Rankin SM. Role of oxidized low density lipoprotein in atherogenesis. Prog Lipid Res 1992;31:127-43.
15. Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992;13:341-90.
16. De Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
17. Tribble DL, Holl LG, Wood PD, Krauss RM. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 1992;93:189-99.
18. Nielsen LB. Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis. Atherosclerosis 1996;123:1-15.
19. Björnheden T, Babyi A, Bondjers G, Wiklund O. Accumulation of lipoprotein fractions and subfractions in the arterial wall, determined in an in vitro perfusion system. Atherosclerosis 1996;123: 43-56.
20. Anber V, Griffin BA. McConnell M, Packard CJ, Shepherd J. Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996;124:261-71.
21. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
22. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 1986;128: 417-31.
23. Swinkels DW, Hak-Lemmers HLM, Demacker PNM. Single spin density gradient ultracentrifugation method for the detection and isolation of light and heavy low density lipoprotein subfractions. J Lipid Res 1987;28:1233-9.
24. Chatterton JE, Schlapfer P, Bütler E, Gutierrez MM, Puppione DL, Pullinger CR, et al. Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering. Biochemistry 1995;34:9571-80.
25. Forte TM, Nordhausen RW. Electron microscopy of negatively stained lipoproteins. Methods Enzymol 1986;128:442-57.
26. Holmquist L, Carlson LA. Subfractionation and characterization of native and incubation enlarged human plasma high density lipoprotein particles by high performance gel filtration. Lipids 1985;20:378-88.
27. Williams MC, Kushwaha RS, McGill HC Jr. Quantification of baboon lipoproteins by high performance gel exclusion chromatography. Lipids 1987;22:366-74.
28. Van Gent T, Van Tol A. Automated gel permeation chromatography of plasma lipoproteins by preparative fast protein liquid chromatography. J Chromatogr 1990;525:433-41.
29. Kieft KA, Bocan TMA, Krause BR. Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography. J Lipid Res 1991;32: 859-66.
30. März W, Siekmeier R, Scharnagl H, Seiffert UB, Gross W. Fast lipoprotein chromatography: new method of analysis for plasma lipoproteins. Clin Chem 1993;39:2276-81.
31. Van den Maagdenberg AMJM, Hofker MH, Krimpenfort PJA, De Bruijn I, Van Vlijmen B, Van der Boom H, et al. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem 1993;268:10540-5.
32. Tallis GA, Shephard MDS, Whiting MJ. Lipoprotein profiling by high performance gel chromatography. Clin Chim Acta 1994;228: 171-9.
33. De Sonnaville JJJ, Colly LP, Wijkel D, Heine RJ. Good glycaemic control in type II diabetic patients in general practice: results of a shared care system. Diabetologia 1993;36:A35.
34. Yoshida Y, Furuta S, Niki E. Effects of metal chelating agents on the oxidation of lipids induced by copper and iron. Biochim Biophys Acta 1993;1210:81-8.
35. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955:34:1345-53.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
37. Markwell MAK, Haas SM, Tolbert NE, Bieber LL. Protein determination in membrane and lipoprotein samples: manual and auto-mated procedures. Methods Enzymol 1981;72:296-303.
38. Lahdenperä S, Puolakka J, Pyörälä T, Luotola H, Taskinen MR. Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens. Atherosclerosis 1996;122:153-62.
39. Williams PT, Krauss RM, Nichols AV, Vranizan KM, Wood PDS. Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. J Lipid Res 1990;31: 1131-9.
40. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;8:307-10.
41. O'Neal D, Grieve G, Rae D, Dragicevic G, Best JD. Factors influencing Lp(a)-particle size as determined by gradient gel electrophoresis. J Lipid Res 1996;37:1655-63.
42. Capell WH, Zambon A, Austin MA, Brunzell JD, Hokanson JE. Compositional differences of LDL particles in normal subjects with LDL subclass phenotype A and LDL subclass phenotype B. Arterioscler Thromb Vasc Biol 1996;16:1040-6.
43. Knott TJ, Pease RJ, Powell LM, Wallis SC, Rall SC Jr. Innerarity TL, et al. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 1986;323:734-8.
44. Carroll RM, Rudel LL. Lipoprotein separation and low density lipoprotein molecular weight determination using high performance gel-filtration chromatography. J Lipid Res 1983;24:200-7.